Alpine Immune Sciences Announces Participation in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference

Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) announced its participation in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference. The event is scheduled for August 10, 2022, at 4:05 p.m. ET. A live webcast will be accessible on the company’s investor relations website, with a replay available for 90 days post-event. Alpine focuses on developing innovative immunotherapies for cancer and autoimmune diseases, boasting a strong pipeline and strategic global collaborations.

Positive

• Participation in Wedbush PacGrow Healthcare Virtual Conference may enhance investor visibility.
• Strong pipeline of clinical and preclinical candidates suggests potential for future growth.

Negative

• None.

SEATTLE--(BUSINESS WIRE)-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the company will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10th, 2022, at 4:05 p.m. ET/1:05 p.m. PT.

A live webcast of the fireside chat will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220804005858/en/

Investor Relations

Alex Sharif

Director, Investor Relations and Corporate Development

Alpine Immune Sciences, Inc.

206-788-4545

ir@alpineimmunesciences.com

Media Relations

Kelli Perkins

Red House

kelli@redhousecomms.com

Source: Alpine Immune Sciences, Inc.

FAQ

When will Alpine Immune Sciences participate in the Wedbush PacGrow Healthcare Virtual Conference?

Alpine Immune Sciences will participate on August 10, 2022, at 4:05 p.m. ET.

Where can I watch the Alpine Immune Sciences fireside chat?

The fireside chat will be available via live webcast on the company's investor relations website.

What is Alpine Immune Sciences focused on?

Alpine Immune Sciences focuses on developing immunotherapy treatments for cancer and autoimmune diseases.